GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
18.35
+1.21 (7.06%)
Dec 20, 2024, 4:00 PM EST - Market closed
Company Description
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection.
The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.
It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California.
GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
GRAIL, Inc.
| Country | United States |
| Founded | 2016 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 1,360 |
| CEO | Robert Ragusa |
Contact Details
Address: 1525 O’Brien Drive Menlo Park, California 94025 United States | |
| Phone | 833-694-2553 |
| Website | grail.com |
Stock Details
| Ticker Symbol | GRAL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001699031 |
| ISIN Number | US3847471014 |
| Employer ID | 86-3673636 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Robert P. Ragusa | Chief Executive Officer and Director |
| Dr. Joshua J. Ofman M.D., M.S.H.S | President |
| Aaron Freidin | Chief Financial Officer |
| Paul Ciccolella | Senior Vice President of Research, Development and Operations |
| Abram Barth J.D., M.P.H. | General Counsel |
| Rodger Currie | Vice President and Head of Government Affairs and Alliance Development |
| Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEng | President Biopharma Business and Europe |
| Dr. Satnam Alag Ph.D. | Senior Vice President of Software Engineering and Chief Security Officer |
| Alice A. Chen | Vice President of Product and Head of Program Management Organization |
| Nathan Hunkapiller Ph.D. | Senior Vice President of Research and Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 15, 2024 | 144 | Filing |
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 13, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 8-K | Current Report |
| Oct 22, 2024 | 8-K | Current Report |
| Oct 11, 2024 | 144 | Filing |
| Oct 7, 2024 | 144 | Filing |
| Oct 7, 2024 | 144 | Filing |
| Sep 30, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |